Liothyronine Sodium Strides Pharma Uk

Liothyronine Sodium, the active ingredient in Liothyronine Sodium Strides Pharma Uk, is a thyroid hormone presented as an oral dosage form for oral use. It treats hypothyroidism, myxedema coma, and provides thyroid hormone replacement therapy.

GNH USA supplies Liothyronine Sodium Strides Pharma Uk as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Liothyronine Sodium is a thyroid hormone that acts on the hypothalamic‑pituitary‑thyroid axis to restore normal metabolic function. - Hypothyroidism: restores deficient T3 levels, improving metabolic rate and alleviating symptoms. - Myxedema coma: provides rapid T3 replacement to reverse severe hypothyroid crisis. - Thyroid hormone replacement therapy: maintains euthyroid status in patients requiring supplemental T3.

Adverse reactions may occur with liothyronine therapy and should be monitored.

Common Side Effects: - Palpitations or rapid heart rate. - Heat intolerance and excessive sweating. - Insomnia or difficulty sleeping. - Anxiety or nervousness. - Tremor of the hands. - Increased appetite.

Serious or Rare Side Effects: - Cardiac arrhythmias, including atrial fibrillation. - Angina pectoris or exacerbation of coronary artery disease. - Heart failure in susceptible individuals. - Severe hyperthyroidism leading to thyroid storm. - Osteoporosis or accelerated bone loss with prolonged high doses. - Allergic reactions such as rash, urticaria, or angioedema.

Liothyronine Sodium requires careful clinical monitoring to minimise risks. - Dose titration: adjust based on serial thyroid function tests and clinical response. - Cardiovascular disease: monitor heart rate, rhythm, and symptoms of angina. - Pregnancy and lactation: use only when clearly indicated after risk‑benefit assessment. - Drug interactions: review concomitant medications that may alter T3 levels or cardiac effects. - Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Liothyronine Sodium can interact with several medicines; awareness helps avoid adverse outcomes.

Major Interactions (Avoid): - Antithyroid drugs (propylthiouracil, methimazole): negate T3 activity. - Beta‑adrenergic agonists (e.g., albuterol): may cause excessive tachycardia. - Digoxin: heightened risk of toxicity due to increased cardiac sensitivity.

Moderate Interactions (Monitor Closely): - Estrogen‑containing oral contraceptives: raise thyroid‑binding globulin, altering free T3 levels. - Calcium or iron supplements: may reduce oral absorption if taken simultaneously.